Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,335
-$388 QoQ
Shares Held
97
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2,794
of 2,820 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Seneschal Advisors, LLC holds $383,931 across 10 Drug Manufacturers - General names. PFE ranks #6 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
309 | $111,894 | |
| 2 | JNJ |
Johnson & Johnson
|
339 | $86,095 | |
| 3 | ABBV |
AbbVie Inc.
|
293 | $73,730 | |
| 4 | MRK |
Merck & Co., Inc.
|
548 | $70,417 | |
| 5 | LLY |
ELI LILLY & Co
|
30 | $35,982 | |
| 6 | PFE |
Pfizer Inc
This page
|
97 | $2,335 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
12 | $1,516 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
24 | $1,382 |
All Filings in PFE
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,335 | 97 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,723 | 97 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $2,414 | 97 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,197 | 47 | Shares | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||